Home › Marginal Zone Lymphoma › Florida › Jacksonville
Marginal Zone Lymphoma clinical trials in Jacksonville, FL
6 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Mayo Clinic Jacksonville, Jacksonville
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Mayo Clinic in Florida, Jacksonville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RecruitingPhase 1
- Mayo Clinic, Jacksonville
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
RecruitingPhase 1
- Mayo Clinic in Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Jacksonville
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Columbus, OH8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Denver, CO7 studies
Other studies in Jacksonville
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer39 studies
- Cancer (all types)29 studies
- Metastatic Cancer28 studies
- Colorectal Cancer27 studies
- Prostate Cancer26 studies
- Obesity25 studies
- Heart Failure21 studies
- Pancreatic Cancer20 studies
- Overweight19 studies
- Multiple Myeloma18 studies
- Lung Cancer17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.